Ena-DATASET-UTMDACC-27-02-2018-23:18:56:158-888 - samples

ABSTRACT: Longitudinal biopsies from a melanoma patient who initially responded to MEK plus CDK4/6 inhibitor therapy were whole exome sequenced to identify potential resistance mutations. The biopsies included normal tissue, pre-treatment, on-treatment, and several post-resistance timepoints.

PROVIDER: EGAD00001003989 | EGA |

REPOSITORIES: EGA